Resources

Publications

01/18/2022
- Oncology
Prevalence of Germline Mutations and Homologous Recombination Deficiency (HRD) in a Real-world Biliary Tract Cancer (BTC) Cohort
ASCO Gastrointestinal Cancers Symposium 2022, Tempus-authored
01/18/2022
- Oncology
Next Generation Sequencing (NGS) to Identify Relapsed Gastrointestinal (GI) Solid Tumor Patients With Human Leukocyte Antigen (HLA) Loss of Heterozygosity (LOH) for Future Logic-Gated CAR T Therapy to Reduce on Target off Tumor Toxicity
ASCO Gastrointestinal Cancers Symposium 2022, Tempus-authored
01/18/2022
- Oncology
Genomic Landscape of ERBB2/3 Alterations in Colorectal Cancer: Comutations, Immuno-Oncology Biomarkers, and Consensus Molecular Subtype
ASCO Gastrointestinal Cancers Symposium 2022, Tempus-authored
01/18/2022
- Oncology
Homologous Recombination Repair Pathway Alterations and Their Relationship to Homologous Recombination Deficiency in Advanced Pancreatic Cancer Patients
ASCO Gastrointestinal Cancers Symposium 2022, Tempus-authored
01/01/2022
- Oncology
Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer
Cancer Research, Tempus-authored
12/21/2021
- Oncology
Validation of Genomic and Transcriptomic Models of Homologous Recombination Deficiency in a Real-World Pan-Cancer Cohort
MedRxiv
12/07/2021
- Oncology
Multi-omic Profiling of Simultaneous Ductal Carcinoma In Situ and Invasive Breast Cancer
San Antonio Breast Cancer Symposium 2021
12/07/2021
- Oncology
Loss of ASXL1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors in ER+ Breast Cancer
San Antonio Breast Cancer Symposium 2021
12/07/2021
- Oncology
The Frequency and Somatic Mutation Landscape of Fibroblast Growth Factor Receptor (FGFR) Alterations in Breast Cancer
San Antonio Breast Cancer Symposium 2021
12/07/2021
- Oncology
Genomic Landscape of HER2-Negative Advanced or Metastatic Breast Cancer with PIK3CA Gain-of-Function Mutations
San Antonio Breast Cancer Symposium 2021

50 51 52